HIGHLIGHTS
- who: Luca Quartuccio from the (UNIVERSITY) have published the paper: Management of mixed cryoglobulinemia with rituximab: evidence and consensus-based recommendations from the Italian Study Group of Cryoglobulinemia (GISC), in the Journal: (JOURNAL)
- what: The research question of the present SLR aimed to look at the benefits and harms of rituximab in mixed cryoglobulinemia (both infectious and non-infectious).
- how: Through a systematic literature review (SLR) and a subsequent consensus conference the authors developed a set of recommendations that the authors suggest as a valuable tool for the physician approaching RTX treatment in . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.